➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
McKinsey
Express Scripts
Mallinckrodt
Merck
Medtronic

Last Updated: September 28, 2020

DrugPatentWatch Database Preview

Litigation Details for Intellectual Ventures I LLC v. Canon Inc. (D. Del. 2013)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Intellectual Ventures I LLC v. Canon Inc. (D. Del. 2013)

Docket   Start Trial Date Filed 2013-03-25
Court District Court, D. Delaware Date Terminated
Cause 35:271 Patent Infringement Assigned To Sue Lewis Robinson
Jury Demand Plaintiff Referred To
Parties CANON INC.; CANON SOLUTIONS AMERICA INC.; CANON U.S.A. INC.; INTELLECTUAL VENTURES I LLC; INTELLECTUAL VENTURES II LLC; MARVELL SEMICONDUCTOR, INC.
Patents RE43,298; RE43,390; RE43,728; RE44,599
Attorneys Andrew Michaels; Brian E. Farnan; C. Austin Ginnings; Dennis J. McMahon; Dillon J. Murphy; Eric Huang; Jaime F Cardenas-Navia; Jason Dorsky; Jonathan Berschadsky; Julia Heaney; Ketan Patel; Kevin P.B. Johnson; Lital Leichtag-Fuks; Marc J. Pensabene; Matthew D. Powers; Michael J. Farnan; Michael P. Sandonato; Monica M. Eno; Nicholas M. Cannella; Palani P. Rathinasamy; Paul T. Ehrlich; Sam Kim; Samantha A. Jameson; Stefani C. Smith; Steven K. Le; Steven S. Cherensky; Suong Nguyen
Firms Farnan LLP; Morris, Nichols, Arsht & Tunnell
Link to Docket External link to docket
Small Molecule Drugs cited in Intellectual Ventures I LLC v. Canon Inc.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial , and   Start Trial .
Biologic Drugs cited in Intellectual Ventures I LLC v. Canon Inc.
The biologic drugs covered by the patents cited in this case are   Start Trial and   Start Trial .

Details for Intellectual Ventures I LLC v. Canon Inc. (D. Del. 2013)

Date Filed Document No. Description Snippet Link To Document
2013-03-25 1 infringement of United States Patent Nos. 5,444,728, 6,130,761, 6,435,686, 6,650,432, RE43,086, 7,315,406, 5,712,870…Ventures I owns United States Patent Nos. 5,444,728, 6,130,761, 6,650,432, RE43,086, 7,315,406, 5,712,870,…forth herein. 44. U.S. Patent No. RE43,086 (“the ’086 patent”), entitled “Method and User Interface… COUNT V: INFRINGEMENT OF U.S. PATENT NO. RE43,086 43. Paragraphs 1 through 10…. 12. United States Patent No. 5,444,728 (“the ’728 patent”), entitled “Laser Driver Circuit External link to document
2013-03-25 3 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 5,444,728; 6,130,761; 6,435,686…,686 B1; 6,650,432 B1; RE43,086 E; 7,315,406 B2; 5,712,870:6,754,195 B2;6,977,944 B2. (els) (Entered: … 25 March 2013 1:13-cv-00473 830 Patent Plaintiff District Court, D. External link to document
2015-11-09 431 ;the '432 patent"), RE43,086 ("the '086 patent"), 7,315,406 ("the '406… and '528 patents and for summary judgment of no secondary considerations (D.I. 298); and IV's… and '528 patents and for summary judgment of no secondary considerations (D.I. 298); denies in part…infringement of nine patents: U.S. Patent Nos. 5,444,728 ("the '728 patent"), 6, 130, 761… B. The Patents-in-Suit The '870 and '944 patents ("the WiFi patents") generally External link to document
2014-01-14 47 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 5,444,728; 6,130,761; US 6,650,4326,650,432 B1; US RE43,086 E; US 7,315,406 B2; 5,712,870; US 6,754,195 B2; US 6,977,944 B2; US 7,817,914 … 25 March 2013 1:13-cv-00473 830 Patent Plaintiff District Court, D. External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
McKinsey
Medtronic
Mallinckrodt
Dow
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.